Genedrive Plc
GDR.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.46M
Close$
Share Statistics
| Market cap | $18.46 Million |
|---|---|
| Enterprise Value | $18.58 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1 |
| Outstanding Shares | 846,094,041 |
Return
| Return on Equity | 3062.17% |
|---|---|
| Return on Assets | -724.52% |
| Return on Invested Capital | -15892.94% |
Valuation & Multiples
| P/E Ratio | -1.06 |
|---|---|
| PEG | -21.94 |
| Price to Sales | - |
| Price to Book Ratio | -1.15 |
| Enterprise Value to Revenue | 11.06 |
| Enterprise Value to EBIT | -1.38 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | -1.2 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 24, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Genedrive Plc
43 employees
CEO: Gino Miele Genedrive Plc, a molecular diagnostics firm established in Manchester, UK, in 2000 (and known as Epistem Holdings Plc until its name change in July 2016), focuses on developing and commercializing innovative point-of-care diagnostic plat...